Karlsruhe – Since 2004 more than 100,000 patients in 30 countries (up to August 2014) have undergone surgery with the TESSYS® method and its later developments. The latest studies reveal a shorter recovery time, a quicker return to work and normal quality of life, and an associated reduction in the impact on welfare systems.
joimax® looks back on 10 years of successful application of the TESSYS® procedure for minimally invasive endoscopic removal of herniated discs – a particularly gentle surgical technique using the naturally occurring transforaminal opening to the spinal canal. TESSYS® was the first product that joimax® launched onto the market and it helped the company make its breakthrough. Since then, joimax® has greatly diversified its product portfolio for 360° surgery in virtually all areas of the spinal column, including endoscopic and percutaneous stabilization.
TES procedure L5-S1 with a large sequester caudally – operation performed by Dr. Menno Iprenburg
Click here to read a newspaper artical on Dutch speed skater Renate Groenewold (2009 world champion over 3000 meters) following her TES operation on 2nd May 2009.
Karlsruhe (GER) — Founded 2001 in Germany, joimax®, the leading manufacturer of medical devices for endoscopic minimally invasive spine surgery, celebrates its 20th anniversary this year. In tandem with this milestone, the company expanded their educational program, ESPINEA®, furthering their global reach.
Despite COVID-19, ESPINEA® (Endoscopic Spine Academy) training programs, which are held in cooperation with the Royal College of Surgeons Edinburgh (RCSEd) and joimax®, were conducted all over the world in 2020, and continue to roll out in 2021. Due to travel restrictions, the programs were adapted to webinars, and remote support and training, totaling 60 sessions last year. By pivoting to online learning, approximately 3000 surgeons were reached in 2020, and 700 surgeons so far in 2021. ESPINEA® was founded by joimax® CEO and Founder Wolfgang Ries in 2019, and was accredited by the RCSEd last year.
“Our goal is to be globally present online, as well as to provide direct local support,” says Ries. “Regardless of lockdowns in many countries, under the ESPINEA® platform, more than 120 surgeons were trained in onsite workshops this quarter, with 70 in the USA and Mexico, 35 in Europe, 15 in Asia, and many more through the joimax® CME-program partnership in China.
ESPINEA® Board Member Alastair Gibson, FRCSEd states: “These efforts demonstrate that joimax® and ESPINEA® can achieve anything together. I’m proud to be part of this impressive blend of online, on-site, and remote events, enabling a strong ESPINEA® community.”
To support the roll out, additional Coronavirus-compliant labs were integrated into the local, onsite education programs. In addition to the company’s existing labs in Karlsruhe and Irvine, California, more labs throughout the USA, including Houston, Minneapolis, New York City, Dallas, and Indianapolis, as well as the Surgical Skills Lab in Mexico City and ORSI Academy in Melle, Belgium, have been added. Also, joimax® opened a branch office in Singapore; the Hong Kong office was opened in spring 2019.
“It is becoming increasingly important to have a personal, on-site presence in order to teach globally-valid learning content,” adds Ries.
Irvine, CA and Karlsruhe, Germany – November 28th, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic Association (COA), which has taken place from Nov 17th to 20th, 2016 at China National Convention Center in Beijing, China. During the exhibition, the new NASS – joimax® MISS Training Centre has been inaugurated.
The 18th Chinese Orthopedic Association Annual Meeting and the 11th International Congress of Chinese Orthopedic Association (COA) this year has again taken place in Beijing and was visited by around 35,000 surgeons gathering for the latest research results and up to date information on technology and clinical progression in orthopedics including Spine Surgery. joimax® had a major presence with a large booth showing its endoscopic minimally invasive product range. Furthermore on the two major meeting days 30 lectures of well-known experts were given at its booth.
Moreover, joimax® also presented its latest product, the newly launched Intracs® Interaoperative Navigation Tracking & Control System for the first time in China.
During the COA the new NASS-joimax® MISS Training Centre in China has been inaugurated on Friday Nov. 18th, 2016. The ceremony has taken place at the joimax® booth together with leaders from the Peking University Third Hospital and members of the NASS Board of Directors. The Chinese market is a very important one for joimax®: Chinese surgeons are highly interested in adopting and deepening their knowledge in endoscopic minimally invasive techniques. joimax® is playing a major role in advanced training and is a driving power in the field of continuing education.
“With the launch of TESSYS® IseeUTM, which has been newly designed especially for the Chinese market, joimax® offers an even more simplified access under facilitated orientation”, says Wolfgang Ries, CEO and founder of joimax®. “The existing TESSYS® trays can furthermore be upgraded with the TESSYS® ISeeUTM supplements” he continues.
From left to right: Edward Dohring, MD, NASS Board of Directors; Prof. Yue Zhou, Xinqiao Hospital, Chairman of Chinese Society for MISS and joimax® faculty; Jeffrey C. Wang, MD, NASS Board of Directors; Prof. Xiaoguang Liu, Vice President Peking University Third Hospital; Prof. Jie Qiao, President Peking University Third Hospital; Wolfgang Ries, CEO & founder joimax® GmbH; Brad Repsold, NASS Assoc. Executive Director; Michael Roberz, International Sales Director joimax® GmbH; Qinguang You, General Manager joimax® China.
Karlsruhe, 23 October 2012. joimax® as the recognized pioneer in endoscopic spine surgery has launched the transforaminal access to the spinal canal under the brand name TESSYS® in 2004. Since then the company has consistently extended its product range and covers the complete array of therapies for spinal disorders with its systems today.
TESSYS® and iLESSYS® are applied especially for the treatment of disc herniations and stenosis utilizing the transforaminal or interlaminar access to the spinal canal, aiming for a long lasting decompression. In the area of pain therapy the company offers the products of the Multiuse series for endoscopic rhizotomy and PeNuts® for percutaneous nucleus therapy. The product range is completed by systems and products in the field of VBA management.
Consequently the next step in the evolution of the joimax® product portfolio is the stabilization and restoration of the spinal column. With the joimax® EndoLIF® programme – the term stands for Endoscopic Lumbar Interbody Fusion – various cage technologies are brought into the intervertebral foramen step by step under endoscopic view. The cage is then being filled with autologous bone or a substitute material under endoscopic control also, the intervertebral disc space and hence the whole spine segment is raised and stabilized. This will be the world’s first interbody fusion device which can be inserted under direct vision.
EndoSphere Spine’s founding members Professors Vijay Goel, PhD and Anand Agarwal, MD at the University of Toledo are among the world leading researchers in the development of biomedical device for the spine. With the assistance of a team at the University of Toledo, they have developed the cage technology, in particular a novel ring cage that is being licensed to joimax® on an exclusive worldwide basis. Prof. Goel is enthusiastic with the idea to position the cage technology using the joimax® minimally invasive access technique: “The combination of our know how with the joimax® expertise leads us to a unique concept that will dramatically push endoscopic spinal surgery forward.” His colleague Prof. Agarwal considers it even a “quantum leap forward”. “In the team at the University of Toledo and the co-founders of EndoSphere Spine, LLC (Profs Goel and Agarwal) we have found a brilliant partner to provide the spine surgeons with state-of-the-art implants for most atraumatic interventions”, adds Wolfgang Ries, CEO and Founder of joimax®.
Both parties share the vision and mission of creating pioneering technologies in order to quickly bring back patients to their usual quality of life in the long run.
About The University of Toledo
Established in 1872, The University of Toledo is home to nearly 22,500 students across 13 colleges and six Ohio campuses. The University offers more than 230 doctoral, professional, graduate and undergraduate programs. UT has earned national and international acclaim for its expertise in medical bioengineering, solar and advanced renewable energy, environmental sciences, astronomical research, translational research and biomarkers.
Karlsruhe, GER– July 15, 2019 –joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the official sales launch of its complete EndoLIF® family. EndoLIF® is an instrument set for endoscopic-assisted minimally invasive lumbar interbody fusion. As already announced and showcased at earlier events, the EndoLIF® product line consists of three members now: the well-known EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the latest EndoLIF® Double Wedge Cage. The complete EndoLIF® product family is now CE-approved and fully available. Moreover, the EndoLIF® O/On-Cage is FDA-approved.
All EndoLIF® Implants are manufactured using a 3D printing process, which ensures an open diamond cell structure. The cages are safely implanted via the guide wire and are fillable with bone or bone substitute material. With their rough and porous surface, the implants guarantee optimal bone ingrowth, stability and finally fusion.
The EndoLIF® Cage family provides the right implant for every patient and is the perfect solution for endoscopic spinal fusion. With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact leaving important biomechanical structures in place after surgery.
Like with any endoscopic procedure compared to open surgery, all advantages for fusion are now given with the EndoLIF® program also. With one EndoLIF® Instrument Set all three cages of the EndoLIF® family can be implemented.
Dr. Florian Zentz, (Munich, GER) emphasizes “the extraordinarily high primary stability of the EndoLIF® DoubleWedge-Cage”. He continues enthusiastically: “After insertion the cage sits very firmly in the intervertebral disc space and adjusts the angulation up to 18 degrees, almost directly enabling an optimal lordosis correction.”
Dr. Ralf Wagner, (Frankfurt, GER) is also convinced of the obvious advantages: “The Delta Cage is ideal for the posterior lumbar interbody fusion (PLIF) offering a gentle posterior alternative, especially at level L5-S1 with its large interlaminar window.
Irvine, California – July 13, 2015 (BUSINESS WIRE) – The German company joimax®, developer of technologies and training methods for minimally invasive endoscopic spinal surgery, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endoscopic Lumbar Interbody Fusion, or EndoLIF® On-Cage.
The EndoLIF On-Cage® consists of titanium alloy, produced with Electron Beam Melt (EBM) technology. The cage displays a porous surface with diamond cell structure, providing an optimal base for cell proliferation and bone growth. Two large openings, which may be filled with autogenous bone, support the creation of a straight column for fusion.
The EndoLIF® implant allows surgeons to utilize an inter-muscular approach, similar to a mini transforaminal lumbar interbody fusion (TLIF), into the intervertebral disc, enabling endoscopic-assisted fusion. Dr. Ralf Wagner, LIGAMENTA Spine Center, Frankfurt and Dr. Bernd Illerhaus, ONZ, Datteln/Recklinghausen, two German spine specialists, have already performed more than 200 out of 600 EndoLIF procedures in Europe. “The access is dura and nerve-gentle, preserves the dorsal bony structures and we can avoid scar tissue because of the stepwise tissue dilation,” said Dr. Illerhaus.
The EndoLIF® On-Cage is designed to be used with supplemental posterior fixation, such as the joimax Percusys® percutaneous pedicle screw-rod system. Cage implantation can be performed with a posterior or postero-lateral approach, either using an open or endoscopic-assisted method.
“With the EndoLIF® program, joimax offers a complete endoscopic-assisted solution for spinal stabilization and fusion. In the future, we will be able to treat patients with even more gentle techniques,” comments Wolfgang Ries, CEO and founder of joimax®. “Our next development will be an EndoLIF® Cage on the basis of our iLESSYS® Delta system for posterior lumbar inter-body fusion (PLIF).”
At the same time joimax® Inc., the US subsidiary celebrates its fifth anniversary, exhibits at the AANS and for the first time awards the Parviz Kambin prize in the frame of the second international TESSYS®-User Meeting in Denver, USA.
Karlsruhe, April 6, 2011. joimax® GmbH holds the 2nd International TESSYS® User Meeting in Denver, USA on April 9th and 10th. At this event, the Karlsruhe based medical device
company starts the celebration activities on the occasion of its 10th anniversary in Germany and its 5th year of existence worldwide – a special occasion in combination with the AANS
Annual Scientific Meeting (American Association of Neurological Surgeons) from April 9th – 13th, 2011.
„We are particularly proud to announce the first ever Parviz Kambin Award“, says Wolfgang Ries, founder and CEO of joimax® GmbH. „With this award we value the neurosurgeon Dr.
Parviz Kambin’s research and work as an important pioneer in the field of minimally invasive spinal surgery. The TESSYS® procedure uses what is known as the Kambin-triangle as its
point of access to the spinal canal.“
The User Meeting offers an optimal platform for TESSYS® users, surgeons, scientists and sales partners to share their experience with the method, further technologies and case
studies as well as learn and test new products and techniques such as the iLESSYS® System, now being launched.
On April 9th, joimax® starts its celebrations with an advanced cadaver workshop which focuses on endoscopic spinal stenosis treatment with TESSYS® Stenosis, the Shrill® Shaver
Drill System and now iLESSYS® method as well. The iLESSYS® method enables the surgeon to fully endoscopically remove transforaminally difficult-to-reach herniated discs and also
stenoses via an interlaminar approach.
The joimax® founder Wolfgang Ries will also give an overview of the history of the company reflecting the past five and ten years of the company and will also provide an outlook on
future products and systems.
The scientific program of the event will include a variety of technical lectures, presentations and discussions on the TESSYS® method including reports on first experiences with the
Shrill® System and iLESSYS®.
joimax® demonstrating its innovative minimally invasive endoscopic spine surgery solutions at Global Spine Congress 2023
Prague, Czech Republic | June 2023 – During this years Global Spine Congress (GSC) joimax® CEO & Founder, Wolfgang Ries, talked to the GSC Chairman, Jeffery Wang, MD, PhD about the latest innovations by joimax®.
Karlsruhe, Germany – February 8, 2018 – the joimax® group announces very strong sales figures for 2017. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery shows a jump of almost 80% vs. 2016 in the U.S. Consolidated sales show a growth of nearly 30%, which reflects its CAGR of 35% since 2008.
“joimax® is in line with its top-line plans as well as with its EBIT growth projections”, states Rainer Schmitz, the long-standing CFO of the joimax® GmbH. “The company is now active in 50 countries and enjoys a strong reputation in Europe, Asia and the U.S.”
Based on the inclusion of the newly created AMA CPT code 62380 for endoscopic decompression of the lumbar spine as of January 1st, 2017, and the worldwide increasing adoption rate of the joimax® procedures in general, the company is gaining a strong foothold throughout the U.S.. The acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the patients and the surgeons are steadily growing worldwide.
The understanding and therapy of SI Joint is a rapidly growing new field worldwide. joimax® faces this growing area of unmet needs with its MultiZYTE® Facet and SI Joint Treatment Set in this market segment. The upcoming 3rd International Conference on Sacroiliac Joint Surgery (ICSJS, http://simeg-international.com/en/home/), taking place in Tampa, FL from Feb. 21 to 24, 2018 gives attendees the opportunity to further enhance the level of understanding of the sacroiliac joint and to participate in a cadaver workshop at CAMLS learning center.
Further success in Asia is a result of the recent approval of the joimax® Endovapor® 2 Multi Radio Frequency System also in China, where joimax® has already been successfully in the market for 10 years.
“With this latest approval we now can market all our systems in this important country, which is a great step towards more targeted patient care” states Wolfgang Ries, Founder and CEO of joimax®.
The Endovapor® 2 generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The device is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. It is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of electro-surgical modes and effects.
Sie sehen gerade einen Platzhalterinhalt von reCAPTCHA. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
